Literature DB >> 25781206

Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.

Parvinder Kaur1, Vikas Gautam2, Rupinder Tewari1.   

Abstract

Stenotrophomonas maltophilia is an emerging nosocomial pathogen responsible for serious human infections. This study was carried out to determine antibiotic susceptibility, resistance mechanisms (integrons, sul1 and sul2), and genetic relatedness (Enterobacterial Repetitive Intergenic Consensus [ERIC]-PCR) among 106 clinical isolates of S. maltophilia from India. Twenty-four (22.6%) of S. maltophilia isolates exhibited resistance to mainstay antibiotic trimethoprim-sulfamethoxazole (TMP-SMX). Except for 2 isolates which contained both TMP-SMX resistance determinants sul1 and sul2 genes, all other 22 TMP-SMX-resistant isolates carried either sul1 (10 isolates) or sul2 (12 isolates) genes. Class 1 integrons were present in 8.5% (9 out of 106) of S. maltophilia isolates, and only 5 out of these isolates were TMP-SMX resistant and positive for sul1 gene. The same isolates also carried resistance cassettes containing qac/smr gene. Minocycline and levofloxacin exhibited the maximum in vitro activity against S. maltophilia. ERIC-PCR revealed high diversity among S. maltophilia isolates. The present study demonstrated high (22.4%) TMP-SMX resistance in clinical isolates of S. maltophilia from India. TMP-SMX-resistant isolates carried relatively higher percentage of sul2 gene than sul1 gene as against the reported literature. Majority (58.3%) of sul1 gene positive were not associated with class 1 integrase gene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25781206     DOI: 10.1089/mdr.2014.0176

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  9 in total

Review 1.  Antibacterial Antifolates: From Development through Resistance to the Next Generation.

Authors:  Alexavier Estrada; Dennis L Wright; Amy C Anderson
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

2.  Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Paulina Paprocka; Angelika Mańkowska; Karol Skłodowski; Grzegorz Król; Tomasz Wollny; Agata Lesiak; Katarzyna Głuszek; Paul B Savage; Bonita Durnaś; Robert Bucki
Journal:  Pathogens       Date:  2022-05-26

3.  Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy.

Authors:  Jin Zhao; Yubin Xing; Wei Liu; Wentao Ni; Chuanqi Wei; Rui Wang; Yunxi Liu; Youning Liu
Journal:  Front Microbiol       Date:  2016-10-26       Impact factor: 5.640

4.  Prevalence of antibiotic resistance and integrons, sul and Smqnr genes in clinical isolates of Stenotrophomonas maltophilia from a tertiary care hospital in Southwest Iran.

Authors:  Hadi Sedigh Ebrahim-Saraie; Hamid Heidari; Behnaz Soltani; Jalal Mardaneh; Mohammad Motamedifar
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

5.  Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).

Authors:  Ana C Gales; Harald Seifert; Deniz Gur; Mariana Castanheira; Ronald N Jones; Helio S Sader
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

6.  Characterization of Phenotypic and Genotypic Diversity of Stenotrophomonas maltophilia Strains Isolated From Selected Hospitals in Iran.

Authors:  Narjess Bostanghadiri; Zohreh Ghalavand; Fatemeh Fallah; Abbas Yadegar; Abdollah Ardebili; Samira Tarashi; Abazar Pournajaf; Jalal Mardaneh; Saeed Shams; Ali Hashemi
Journal:  Front Microbiol       Date:  2019-05-29       Impact factor: 5.640

7.  Risk Factors for Mortality in Hospitalized Patients with Stenotrophomonas maltophilia Bacteremia.

Authors:  Jiyong Jian; Zeqiang Xie; Liang Chen
Journal:  Infect Drug Resist       Date:  2022-07-21       Impact factor: 4.177

8.  Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China.

Authors:  Li-Fen Hu; Guo-Sheng Chen; Qin-Xiang Kong; Li-Ping Gao; Xi Chen; Ying Ye; Jia-Bin Li
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

9.  Taxonogenomics reveal multiple novel genomospecies associated with clinical isolates of Stenotrophomonas maltophilia.

Authors:  Prashant P Patil; Sanjeet Kumar; Samriti Midha; Vikas Gautam; Prabhu B Patil
Journal:  Microb Genom       Date:  2018-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.